Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Combination Gel and Vascular ND in Mild to Moderate Rosacea

This study has been completed.
Sponsor:
Collaborator:
Bayer
Information provided by (Responsible Party):
Amy McMichael, Wake Forest University
ClinicalTrials.gov Identifier:
NCT01631656
First received: June 27, 2012
Last updated: May 5, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2011
  Primary Completion Date: February 2011 (Final data collection date for primary outcome measure)